Company news

CANbridge Pharmaceuticals Inc. news in 2024

CANbridge Pharmaceuticals Inc.'s news releases, calls and decks from 2024, newest first.

View company

CANbridge Pharmaceuticals Successfully Obtains Drug Manufacturing License Type B Certificate

October 29, 2024

CANbridge Reports Positive Topline Data from CAN103 Pivotal Trial for Gaucher Disease in China, Plans NDA Filing in Q4 2024

August 19, 2024